Finance

Beta
Lists
BNGO:NASDAQ
BioNano Genomics Inc
$1.17
-7.14%
(-0.090) 1D
$1.19
+1.67% (+0.020)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BNGO...
Open
$1.25
High
$1.26
Low
$1.17
Mkt. cap
13.43M
Avg. vol.
162.08K
Volume
212.37K
52-wk high
$5.50
52-wk low
$1.06
EPS
-$5.11
Beta
1.65
Shares outstanding
11.48M
No. of employees
96
Open
$1.25
High
$1.26
Low
$1.17
Mkt. cap
13.43M
Avg. vol.
162.08K
Volume
212.37K
52-wk high
$5.50
52-wk low
$1.06
EPS
-$5.11
Beta
1.65
Shares outstanding
11.48M
No. of employees
96
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to BNGO in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for BNGO in the last 3 months.
Highest
Current $1.17
$6.00 (+412.82%)
Average
$5.00 (+327.35%)
Lowest
$4.00 (+241.88%)
News stories
From sources across the web
About BioNano Genomics Inc
CEOErik Holmlin
Employees96
Founded2003
HeadquartersSan Diego, California, United States
SectorHealth care
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.73M
7.37M
7.95M
6.69M
Cost of goods sold
3.26M
4.00M
4.55M
3.44M
Cost of revenue
3.26M
4.00M
4.55M
3.44M
Research and development expenses
2.93M
2.84M
3.23M
3.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.35M
9.06M
8.71M
8.01M
Operating expense
11.28M
11.91M
11.94M
11.15M
Total operating expenses
14.53M
15.90M
16.49M
14.58M
Operating income
-7.80M
-8.54M
-8.54M
-7.90M
Other non operating income
749.00K
-150.00K
434.00K
-619.00K
EBT including unusual items
-6.85M
-8.49M
-7.90M
-8.29M
EBT excluding unusual items
-6.85M
-8.49M
-7.90M
-8.29M
Income tax expense
10.00K
14.00K
35.00K
10.00K
Effective tax rate
-0.15%
-0.16%
-0.44%
-0.12%
Other operating expenses
-
-
-
-
Net income
-6.86M
-8.50M
-7.93M
-8.30M
Net profit margin
-101.84%
-115.42%
-99.77%
-124.17%
Earnings per share
-1.97
-1.59
-0.03
-0.75
Interest and investment income
277.00K
268.00K
276.00K
223.00K
Interest expense
-73.00K
-69.00K
-72.00K
-
Net interest expenses
204.00K
199.00K
204.00K
223.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.37M
-6.11M
-6.35M
-5.59M
Gain or loss from assets sale
239.00K
-
-
34.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more